Edico Genome

Edico Genome

Signal active

Organization

Contact Information

Overview

Edico Genome develops bioinformatics processor chips for DNA analysis designed to analyze sequencing data. The company's DRAGEN platform uses a field-programmable gate array to provide hardware-accelerated implementations of genome pipeline algorithms, such as BCL conversion, compression, mapping, alignment, sorting, duplicate marking, and haplotype variant calling, enabling healthcare institutions to easily discover links between DNA sequence variations and human disease.

About

Industries

Big Data, Biotechnology, Health Care, Genetics

Founded

2013

Employees

11-50

Headquarters locations

San Diego, California, United States, North America

Social

Profile Resume

Edico Genome headquartered in United States, North America, operates in the Big Data, Biotechnology, Health Care, Genetics sector. The company focuses on Big Data and has secured $2.0B in funding across 64 round(s). With a team of 11-50 employees, Edico Genome is actively contributing to advancements in Big Data. Their latest funding round, Series A - Edico Genome, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Rebecca Hemenway

Rebecca Hemenway

Sr. Director Business Development

Funding Rounds

Funding rounds

4

Investors

5

Lead Investors

0

Total Funding Amount

$32.0M

Details

3

Edico Genome has raised a total of $32.0M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2014Early Stage Venture
2017Early Stage Venture22.0M
2014Early Stage Venture10.0M

Investors

Edico Genome is funded by 18 investors.

Investor NameLead InvestorFunding RoundPartners
Dell Technologies Capital-FUNDING ROUND - Dell Technologies Capital10.0M
EvoNexus-FUNDING ROUND - EvoNexus10.0M
Edico Genome-FUNDING ROUND - Edico Genome10.0M
Seed San Diego-FUNDING ROUND - Seed San Diego10.0M